Stablecoin Development Corp. (SDEV) Stock
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Stablecoin Development Corp.
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Stablecoin Development Corp. is led by CEO Michael Kazley, employs 4 people, headquartered in US, publicly traded since 2026.
Stablecoin Development Corp. (SDEV) stock trades at $1.13 with a market capitalization of $30.51M. The stock is valued at a price-to-earnings (P/E) ratio of 0.06, price-to-book of 0.21, price-to-sales of 12.22. Over the past 52 weeks the stock has ranged between $1.00 and $2.13, and currently trades 46.9% below its 52-week high. It pays a dividend yielding 3.60%.
On profitability, Stablecoin Development Corp. generates a return on equity (ROE) of 2791.30% — well above the market average, a sign of a high-quality business, return on capital employed of -2.99%, an operating margin of -2.14%, a net profit margin of 212.18%.
Official website: www.stablecoindev.com